About Embryyo Technologies Private Limited
Data last updated:
Embryyo Technologies Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 17 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2014PTC150648. Its GSTIN is 27AADCE6743L1ZA (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prateek Jain and Nishant Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹15.38 Lakh (net margin 12.7%) and EBITDA of ₹17.12 Lakh (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 5% over five years.
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Embryyo.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website embryyo.com.
Company details
Contact details
Embryyo Technologies Private Limited's registered office is in Pune, Maharashtra. Its website is embryyo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No. 301 S. No. 14 Vasundhara Plaza, Near Bramharund Pimple Nilakh, Pune, Maharashtra, India – 411027
- IndustryHealthcare, HealthTech & Medical Tech Solutions
To see the full contact details of Embryyo Technologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Embryyo Technologies operates one associated brand: Embryyo. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Medical devices are designed and produced via R&D processes. | embryyo.com |
Business activity
The main business activity of Embryyo Technologies is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Embryyo Technologies Private Limited, buy the company report.
Financials of Embryyo Technologies Private Limited
FY 2025 filings availableEmbryyo Technologies Private Limited reported revenue of ₹1.21 Cr (up 233% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 233% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.38 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | 12.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Embryyo Technologies Private Limited, buy the company report.
Board of directors of Embryyo Technologies Private Limited
Embryyo Technologies has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prateek Jain Also directs: Embryyotech Product Development Centre Private Limited | Director | 24 Nov 2014 | 11 Years 11 Months | Current |
| Nishant Kumar | Director | 17 Feb 2014 | 12 Years 8 Months | Current |
Auditor
Embryyo Technologies Private Limited is audited by Baheti & Somani LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Baheti & Somani LLP | FY 2022 | 124298W |
Shareholding
The shareholding of Embryyo Technologies Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Embryyo Technologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Embryyo Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Embryyo Technologies Private Limited has 6 MSME Form 1 returns on record between 2022 and 2023, listing 53 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Avant Edge Business Consulting Private Limited | |||
| 3 Deology 3D Printing Services | |||
| Fox Mandal & Associates |
To see the full MSME payment records of Embryyo Technologies Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Embryyo Technologies has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Embryyo Bio-Microdevices Private Limited | U73200PN2016PTC165279 |
To see the full group structure of Embryyo Technologies Private Limited, buy the company report.
GST
Embryyo Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCE6743L1ZA | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Embryyo Technologies Private Limited, buy the company report.
Recent activity
Embryyo Technologies Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Kiran Bala Sinha ceased to be Director on 02 Jul 2018.
Frequently asked questions
Embryyo Technologies is an active private limited company based in Pune, Maharashtra, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 17 February 2014 (12+ years old) and is registered under CIN U74900PN2014PTC150648.
Embryyo Technologies has 2 current directors:
- Prateek Jain - Director
- Nishant Kumar - Director
The latest financial statements of Embryyo Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Embryyo Technologies is 27AADCE6743L1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Embryyo Technologies is U74900PN2014PTC150648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Embryyo Technologies was incorporated on 17 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
Kiran Bala Sinha ceased to be Director on 02 Jul 2018. Prateek Jain ceased to be Additional Director on 31 Dec 2015. Prateek Jain was appointed as Director on 24 Nov 2014. Embryyo Technologies has 4 board changes on record in total.
Embryyo Technologies has 6 MSME Form 1 returns on record between 2022 and 2023, listing 53 overdue payments to 3 micro and small suppliers. The latest return was filed on 21 Oct 2023.
Embryyo Technologies can be reached through the website embryyo.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Embryyo Technologies is at Flat No. 301 S. No. 14 Vasundhara Plaza, Near Bramharund Pimple Nilakh, Pune, Maharashtra, India – 411027.
Embryyo Technologies operates in the healthcare industry, in the healthtech and medical tech solutions segment.